A group based on complementary expertise with multidisciplinary know-how

A range of integrated biotechnology solutions

News

Smaltis

SMALTIS joins the Biotech Investissement Group!

Date of publication : 25/07/2019

We are pleased to announce the entry of Biotech Investissement into the capital of SMALTIS SAS, a company based in Besançon (France), which joins RD-Biotech SAS, Diaclone SAS, SynAbs SA and QVQ Holding within the group (www.mabexperts.com).

Created in 2014, SMALTIS (www.smaltis.fr) has a solid expertise in Microbiology and an innovative experience in Bacterial Genetics. Thanks to its know-how, SMALTIS designs tailor-made methods and delivers mutant bacteria with high added value for the development, manufacturing and quality control stages of health products. The company is now specialized in three major activities related to public health challenges: Antibiotic resistance and infection control, exploration of Microbiota and engineering Bacterial Mutants.

By joining the Biotech Investissement group, SMALTIS is consolidating already well-established expertise in the fields of Bioproduction and related quality controls, by adding Microbiological and Bacterial Genetic Engineering expertise.

Contact:

Phone +33(0)3 81 53 88 37 – Mail : info@mabexperts.com

  • Munich
    German Society for Immunology (DGfl)
    Date of publication : 29/07/2019

    The mAbexperts Group will be present at the German society meeting for Immunology (DGfl) - Munchen (Germany) – September 10th to 13th 2019.

    Come and meet us on our booth! We will be happy to...

    Read more
  • 4th edition of “Bioproduction des Immunothérapies”
    Date of publication : 29/07/2019

    The mAbexperts Group will be present at the 4th  edition of “Bioproduction des immunothérapies” organized by Mabdesign at BIOCITECH – Romainville (FR) – September...

    Read more
  • Plasmids
    RD-BIOTECH PLASMID MANUFACTURING SERVICE. Plasmid DNA for research, preclinical and clinical applications scaled to fit projects of any size.
    Date of publication : 25/07/2019

    RD-Biotech has been perfecting plasmid DNA production for more than 17 years for a wide range of research, preclinical, clinical and diagnostic applications.

    You need 1mg of DNA for a research...

    Read more
  • Smaltis
    SMALTIS joins the Biotech Investissement Group!
    Date of publication : 25/07/2019

    We are pleased to announce the entry of Biotech Investissement into the capital of SMALTIS SAS, a company based in Besançon (France), which joins RD-Biotech SAS, Diaclone SAS, SynAbs SA and...

    Read more
  • Diaclone - Promo d'été sur la gamme ELISpot
    Date of publication : 04/07/2019
  • FAST ELISA
    Discover and test the RD-BIOTECH fastELISA Kits:
    Date of publication : 21/05/2019

    Discover and test the RD-BIOTECH fastELISA Kits: The quickest ELISA Kits on the market!

    Easy one-step process – Results in less than 30 minutes – Coloured pipetting tracking –...

    Read more
  • CAM FAMILY
    The CAM family: A new target for monitoring or treating cancers?
    Date of publication : 21/05/2019

    The cell adhesion molecules (CAMs) family includes more than 50 proteins with four main groups: immunoglobulin (Ig)-like CAMs, cadherins, selectins, and integrins.

    Diaclone has been interested for...

    Read more
  • PSL
    PSL Alliance
    Date of publication : 18/05/2019

    Diaclone is a core member of the PSL Alliance, a network of biotech companies gathered by UK-based company Pivotal Scientific...

    Read more
  • IL-17
    DIACLONE Assays for the Human IL-17 Family
    Date of publication : 23/04/2019

    DIACLONE has developed one of the largest ranges of ELISA and ELISpot kits available for the detection of Human IL-17A, IL-17F and IL-17A/F:




    Human IL-17A ELISpot...

    Read more
  • Prod cell
    NEW! RD-Biotech supplier of murine monoclonal antibodies D1-25 and 1112-1, for the quantification of rabies virus by ELISA.
    Date of publication : 08/04/2019

    Signature of license agreements with Institut Pasteur – France and with Winstar Institute- USA: RD-Biotech becomes the supplier of the clones D1-25 and 1112-1 and now offers the antibody pair...

    Read more
  • Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.
    Date of publication : 21/08/2018

    Le Projet MiMédi

    MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

    Au sein...

    Read more